BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11726118)

  • 1. Utility of the in situ detection of HPV in Pap smears diagnosed as within normal limits.
    Menezes G; Euscher E; Schwartz B; Catania F; Chancellor J; Nuovo GJ
    Acta Cytol; 2001; 45(6):919-26. PubMed ID: 11726118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human papillomavirus in Papanicolaou smears: correlation with pathologic findings and clinical outcome.
    Nuovo GJ
    Diagn Mol Pathol; 1998 Jun; 7(3):158-63. PubMed ID: 9836071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization.
    Manavi M; Bauer M; Pischinger K; Czerwenka K
    Arch Pathol Lab Med; 2001 Mar; 125(3):353-7. PubMed ID: 11231482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Pap smear, cervical biopsy, and clinical follow-up with an HPV typing microarray system.
    Nuovo GJ; Bartholomew D; Jung WW; Han IK; Um T; Grabarz DF; Lee DJ; McCabe RT
    Diagn Mol Pathol; 2008 Jun; 17(2):107-11. PubMed ID: 18382353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods.
    Levi AW; Kelly DP; Rosenthal DL; Ronnett BM
    Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions.
    Morrison C; Prokorym P; Piquero C; Wakely PE; Nuovo GJ
    Cancer; 2003 Apr; 99(2):75-82. PubMed ID: 12704686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral.
    Fait G; Kupferminc MJ; Daniel Y; Geva E; Ron IG; Lessing JB; Bar-Am A
    Gynecol Oncol; 2000 Nov; 79(2):177-80. PubMed ID: 11063640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
    Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
    Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
    Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
    Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness of Hybrid Capture II detection of high-risk human papillomavirus in women with abnormal pap-smears of the uterine cervix].
    Tena D; Garrido N; Menéndez JM; Delgado JJ; Romanyk J; González Mdel R; Zapico A; Beltrán M
    Enferm Infecc Microbiol Clin; 2005 Oct; 23(8):474-8. PubMed ID: 16185561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
    Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
    JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of a liquid-based Pap test and concurrent HPV DNA assay of residual samples. A study of 608 cases.
    Hong IS; Marshalleck J; Williams RH; Gaiter TE; Mielzynska-Lohnas I; Kim K
    Acta Cytol; 2002; 46(5):828-34. PubMed ID: 12365215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
    Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
    J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
    Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
    J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of atypical Papanicolaou tests from ThinPreps of postmenopausal women receiving hormone replacement therapy.
    Menezes GA; Wakely PE; Stripe DM; Nuovo GJ
    Cancer; 2001 Dec; 93(6):357-63. PubMed ID: 11748575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J; Lazcano-Ponce E; Lorincz A; Hernández M; Hernández P; Leyva A; Uribe M; Manzanares H; Antunez A; Carmona E; Ronnett BM; Sherman ME; Bishai D; Ferris D; Flores Y; Yunes E; Shah KV
    Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
    Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
    J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
    Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
    Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli AC; Bovicelli A; Zamparelli A; Bovicelli L
    Acta Cytol; 2000; 44(3):310-8. PubMed ID: 10833984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.